CP-154,526

CP-154,526
	200px
Names
	IUPAC name N-butyl-N-ethyl-2,5-dimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[3,2-e]pyrimidin-4-amine
Identifiers
CAS Number	157286-86-7
ChEMBL	ChEMBL9946
ChemSpider	4470592
IUPHAR/BPS	3495
Jmol 3D model	Interactive image
PubChem	5311055
	InChI InChI=1S/C23H32N4/c1-8-10-11-26(9-2)22-20-18(6)14-27(23(20)25-19(7)24-22)21-16(4)12-15(3)13-17(21)5/h12-14H,8-11H2,1-7H3 Key: FHQYJZCJRZHINA-UHFFFAOYSA-N ; InChI=1/C23H32N4/c1-8-10-11-26(9-2)22-20-18(6)14-27(23(20)25-19(7)24-22)21-16(4)12-15(3)13-17(21)5/h12-14H,8-11H2,1-7H3 Key: FHQYJZCJRZHINA-UHFFFAOYAW ;
	SMILES CCCCN(CC)C1=NC(=NC2=C1C(=CN2C3=C(C=C(C=C3C)C)C)C)C ;
Properties
Chemical formula	C23H32N4
Molar mass	364.52698
Vapor pressure	{{{value}}}
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

CP-154,526 is a potent and selective antagonist of the corticotropin releasing hormone receptor 1 developed by Pfizer.^[1]

CP-154,526 is under investigation for the potential treatment of alcoholism.^[2]^[3]

References

CP 154526 at the US National Library of Medicine Medical Subject Headings (MeSH)

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.